Next Choice
Product Images NDC 52959-450

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Next Choice (NDC 52959-450). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levonorgestrel Structural And Molecular Formula (Next Choice 1)

Chemical structure of the active ingredient for Next Choice by H.J. Harkins Company, Inc. The structure depicts a steroid framework with hydroxyl and ketone functional groups, including a terminal alkyne moiety, consistent with a progestin compound.*

FDA Label Image

Principal Display Panelndc 52544-275-36next Choice™ (levonorgestrel) Tablets 0.75 mg (Next Choice 2)

Next Choice medication carton label with NDC 52959-450-02, manufactured by Watson Lab in Corona, CA. The label indicates the lot number NXC00WL and expiration date 04/11. It describes the tablet as an orange, round pill and compares it to Plan B (NDC 52544-275-36). Usage instructions advise to follow doctor's directions or see outer packaging for dosage. The label also contains barcodes and cautionary storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.